- Home
- ANEB vs WHWK Comparison
ANEB vs WHWK Comparison
Compare ANEB & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- WHWK
- Stock Information
- Founded
- ANEB 2020
- WHWK 2007
- Country
- ANEB United States
- WHWK United States
- Employees
- ANEB N/A
- WHWK N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- ANEB Health Care
- WHWK Health Care
- Exchange
- ANEB Nasdaq
- WHWK Nasdaq
- Market Cap
- ANEB 111.8M
- WHWK 95.2M
- IPO Year
- ANEB 2021
- WHWK N/A
- Fundamental
- Price
- ANEB $2.76
- WHWK $2.37
- Analyst Decision
- ANEB Buy
- WHWK
- Analyst Count
- ANEB 2
- WHWK 0
- Target Price
- ANEB $8.00
- WHWK N/A
- AVG Volume (30 Days)
- ANEB 25.7K
- WHWK 5.1M
- Earning Date
- ANEB 11-12-2025
- WHWK 11-15-2025
- Dividend Yield
- ANEB N/A
- WHWK N/A
- EPS Growth
- ANEB N/A
- WHWK N/A
- EPS
- ANEB N/A
- WHWK N/A
- Revenue
- ANEB N/A
- WHWK $21,596,000.00
- Revenue This Year
- ANEB N/A
- WHWK N/A
- Revenue Next Year
- ANEB N/A
- WHWK N/A
- P/E Ratio
- ANEB N/A
- WHWK N/A
- Revenue Growth
- ANEB N/A
- WHWK N/A
- 52 Week Low
- ANEB $0.80
- WHWK $1.39
- 52 Week High
- ANEB $3.42
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- ANEB 64.17
- WHWK 55.43
- Support Level
- ANEB $2.50
- WHWK $2.26
- Resistance Level
- ANEB $2.76
- WHWK $2.72
- Average True Range (ATR)
- ANEB 0.12
- WHWK 0.32
- MACD
- ANEB 0.03
- WHWK 0.01
- Stochastic Oscillator
- ANEB 85.00
- WHWK 26.32
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.